about-us-2023-1920x760.jpg

About Us

At Avantor, we set science in motion by enabling innovation across the life sciences and technology industries with the highest quality products, services, and solutions to support every step of the scientific journey. Bringing together our comprehensive portfolio, productivity-enhancing technology and global manufacturing and distribution capabilities, we are a proven partner in highly regulated environments.

spacer-1x1.gif
75+
Manufacturing & Distribution Facilities
spacer-1x1.gif
13
Innovation Centers
spacer-1x1.gif
14
cGMP Facilities
spacer-1x1.gif
~60
ISO Certified Facilities
spacer-1x1.gif
6M+
Products Distributed Globally

Who We Are

BHI-1966-540x390.jpg

Our mission, vision and values are the backbone of our company

230322-ritter-ceo-tour-104-540x390.jpg

Our leadership team has come from world-class companies

avantor-dub-hr-29-540x390.jpg

Founded in 1904 by John Townsend (J.T.) Baker, our history is routed in science

OurDEICommitment_540x390.jpg

We are dedicated to creating a fully inclusive culture that celebrates diversity and creates equitable opportunities for all.

ABCS7475-540x390.jpg

Strategically located to support our customers’ needs

We set science in motion to create a better world

Every day, science has the power to change lives for the better. We have a passion for science and work side by side with the scientific community: pioneers, scientists, innovators and educators to help solve the world’s most complex challenges.

Featured content

general-healthcare-540x390.jpg

Avantor NuSil® R&D Scientist Sandra Ortega shares her path to a career in research and discusses developing high-purity silicone applications for the medical devices, aerospace exploration and defense system industries.

Learn more

TurningObstaclesIntoOpportunitiesColumnCardThumbnail.png

Addressing opportunities in gene therapy, and finding better characterization solutions using platform technologies are paramount because failure to do so can result in serious adverse events or lead to trial failure of effective therapeutics due to manufacturing shortcomings.

Learn more

monoclonal-antibodies-824641956-540x390.jpg

This article discusses the latest research in excipients and buffer composition in reducing viscosity and aggregation, as well as preventing degradation, to develop a stable and patient-friendly commercial mAb.

Learn more

Our-Products-img.jpg

Our Products

From discovery to delivery, our portfolio is used in virtually every stage of research, development and production.

Learn more